QUESTCOR PHARMACEUTICALS INC (QCOR) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 600 transactions totaling $335.7M, demonstrating a bearish sentiment with -$326.2M in net insider flow. The most recent transaction on Aug 14, 2014 involved a transaction of 1,818,248 shares valued at $0.
No significant insider buying has been recorded for QCOR in the recent period.
No significant insider selling has been recorded for QCOR in the recent period.
Based on recent SEC filings, insider sentiment for QCOR is bearish with an Insider Alignment Score of 1/100 and a net flow of -$326.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at QUESTCOR PHARMACEUTICALS INC (QCOR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading QCOR stock, having executed 600 transactions in the past 90 days. The most active insider is Don M. Bailey (Executive), who has made 168 transactions totaling $83.8M.
Get notified when executives and directors at QCOR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 14, 2014 | Lp Broadwood Partners | Executive | Other | 1,818,248 | $N/A | $0 | |
| Aug 14, 2014 | Lp Broadwood Partners | Executive | Disposition | 11,683 | $N/A | $0 | |
| Aug 14, 2014 | Lp Broadwood Partners | Executive | Other | 0 | $N/A | $0 | |
| Aug 14, 2014 | C. Russell Angus | Executive | Disposition | 3,835 | $N/A | $0 | |
| Aug 14, 2014 | C. Russell Angus | Executive | Disposition | 4,529 | $N/A | $0 | |
| Aug 14, 2014 | H. Mulroy Michael | Executive | Disposition | 16,072 | $N/A | $0 | |
| Aug 14, 2014 | H. Mulroy Michael | Executive | Disposition | 18,000 | $N/A | $0 | |
| Aug 14, 2014 | H. Mulroy Michael | Executive | Disposition | 39,187 | $N/A | $0 | |
| Aug 14, 2014 | D. Thompson Virgil | Executive | Disposition | 29,867 | $N/A | $0 | |
| Aug 14, 2014 | Asarpota Rajesh | Executive | Disposition | 20,000 | $N/A | $0 | |
| Aug 14, 2014 | Asarpota Rajesh | Executive | Disposition | 4,000 | $N/A | $0 | |
| Aug 14, 2014 | Kelly Martin G. | Executive | Disposition | 2,812 | $N/A | $0 | |
| Aug 14, 2014 | C. Farrell Stephen | Executive | Disposition | 11,683 | $N/A | $0 | |
| Aug 14, 2014 | M. Whitcup Scott | Executive | Disposition | 4,183 | $N/A | $0 | |
| Aug 14, 2014 | Jeffrey Medeiros David | Executive | Disposition | 26,687 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 266 | $331.0M | 89.3% |
Exercise(M) | 201 | $21.0M | 5.7% |
Payment(F) | 9 | $10.2M | 2.8% |
Purchase(P) | 12 | $4.8M | 1.3% |
Disposition(D) | 42 | $3.5M | 0.9% |
Award(A) | 59 | $29.0K | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Gift(G) | 9 | $0 | 0.0% |
Insider selling pressure at QUESTCOR PHARMACEUTICALS INC has increased, with 22 insiders executing 600 transactions across all time. Total sales of $331.0M significantly outpace purchases of $4.8M, resulting in a net outflow of $326.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.